| Balance Sheets | 2025-07-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 52,769 | |||
| Prepaid clinical costs | 1,045 | |||
| Other receivables | 1,206 | |||
| Accounts receivable, net of allowance for credit losses of 245 at july 31, 2025 and july 31, 2024 | 627 | |||
| Inventory | 281 | |||
| Prepaid expenses and other current assets | 786 | |||
| Total current assets | 56,714 | |||
| Property and equipment, gross | 2,608 | |||
| Less accumulated depreciation and amortization | 1,012 | |||
| Property and equipment, net | 1,596 | |||
| Non-current prepaid clinical costs | 1,399 | |||
| Convertible notes receivable classified as available-for-sale | 1,858 | |||
| Goodwill | 19,939 | |||
| Intangible assets, net | 994 | |||
| In-process research and development | 31,575 | |||
| Other assets | 34 | |||
| Total assets | 114,109 | |||
| Accounts payable | 6,893 | |||
| Accrued expenses | 3,304 | |||
| Convertible notes payable | 614 | |||
| Other current liabilities | 66 | |||
| Due to related parties-Related Party | 723 | |||
| Total current liabilities | 11,600 | |||
| Accrued expenses, noncurrent | 3,895 | |||
| Convertible notes payable, noncurrent | 78 | |||
| Other liabilities | 27 | |||
| Deferred income tax liability | 138 | |||
| Total liabilities | 15,738 | |||
| Common stock value-Common Class A | 8 | |||
| Common stock value-Common Class B | 508 | |||
| Additional paid-in capital | 322,161 | |||
| Accumulated deficit | -232,263 | |||
| Treasury stock, at cost 101,487 class b shares as of july 31, 2025 and july 31, 2024 | 168 | |||
| Accumulated other comprehensive income related to unrealized income on available-for-sale securities | 358 | |||
| Accumulated other comprehensive income related to foreign currency translation adjustment | 3,787 | |||
| Total equity attributable to rafael holdings, inc | 94,391 | |||
| Noncontrolling interests | 3,980 | |||
| Total equity | 98,371 | |||
| Total liabilities and equity | 114,109 | |||
Rafael Holdings, Inc. (RFL)
Rafael Holdings, Inc. (RFL)